The following is a summary of the Reckitt Benckiser Group Plc (RBGPF) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Reckitt Benckiser reported a like-for-like net volume increase of 1.4% across their Hygiene and Health portfolios in Q1 2024.

• The Nutrition division experienced a 9.9% decline in net revenue, caused by a negative volume of 9.4% and a 0.5% drop from price/mix.

• Hygiene business saw a 7.1% like-for-like net revenue increase, majorly contributed by Finish and Lysol brands.

• Health segment saw a 1% increase in like-for-like net revenue led by Durex, Dettol, VMS, and Gaviscon brands.

• Reckitt Benckiser's revenue and profit guidance are heavily weighted towards H2, indicating expected margin growth during this period.

Business Progress:

• North America saw growth in hygiene brands in Q1 2024, developing markets such as India and China experienced mid-single-digit volume growth.

• Reckitt Benckiser's innovations, like Durex Invisible and recently launched Lysol Air Sanitizer, are stimulating growth.

• High performing areas such as OTC, Intimate wellness, and Finish will continue to receive investment for continued growth.

• The accelerated share buyback program has seen £600 million of shares purchased to date, with another round expected to commence in July.

• The company plans to launch new innovations and platforms over the next year, promoting portfolio advancement and shareholder value.

• Progress in their strategic agenda is ongoing, with an update expected in their half-year results. Despite being involved in a complex litigation process, Reckitt Benckiser remains committed to its current strategic path.

More details: RECKITT BENCKISER GROUP PLC IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.